BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Prognosis
2073 results:

  • 1. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
    Stoyukhina AS
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data.
    Hong S; Lee JH; Heo JY; Suh KJ; Kim SH; Kim YJ; Kim JH
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):186. PubMed ID: 38600328
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study.
    Py C; De Vito C; Tsantoulis P; Kaya G; Labidi-Galy SI; Dietrich PY
    Swiss Med Wkly; 2023 Dec; 153():3504. PubMed ID: 38579317
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Malignancy After Living Donor Liver Transplantation.
    Kobayashi T; Miura K; Ishikawa H; Sakata J; Takizawa K; Hirose Y; Toge K; Saito S; Abe S; Kawachi Y; Ichikawa H; Shimada Y; Takahashi Y; Wakai T; Kinoshita Y
    Transplant Proc; 2024 Apr; 56(3):660-666. PubMed ID: 38519268
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting.
    Khan F; Hashmi F; Ghahramanyan N; Baloyan E; Tamamyan G; Konopleva M; Pemmaraju N; Voskanyan A
    Oncology (Williston Park); 2024 Mar; 38(3):104-106. PubMed ID: 38517410
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effects of COVID-19 Pandemic on the Diagnosis of Melanoma and Keratinocyte Carcinomas: a Systematic Review and Meta-analysis.
    Díaz-Calvillo P; Muñoz-Barba D; Ureña-Paniego C; Maul LV; Cerminara S; Kostner L; Martínez López A; Arias-Santiago S
    Acta Derm Venereol; 2024 Mar; 104():adv19460. PubMed ID: 38483083
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
    Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
    Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma.
    Tan SX; Chong S; Rowe C; Galbraith J; Dight J; Zhou C; Malt M; Smithers BM; Khosrotehrani K
    Exp Dermatol; 2024 Mar; 33(3):e15041. PubMed ID: 38433382
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Superficial dedifferentiated liposarcoma: A clinicopathologic study.
    Bourgeau M; Gandhi JS; Deeb KK; Bahrami A
    Hum Pathol; 2024 Mar; 145():63-70. PubMed ID: 38423223
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Assessment of Social Vulnerabilities of Care and prognosis in Adult Ocular Melanomas in the US.
    Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
    Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nivolumab Rechallenge After Immune-related Adverse Events in Patients With Unresectable Advanced or Recurrent Esophageal cancer.
    Ueno K; Suzuki K; Saito K; Shinohara H; Miura A
    In Vivo; 2024; 38(2):794-799. PubMed ID: 38418136
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. On-Site Melanoma Diagnosis Utilizing a Swellable Microneedle-Assisted skin Interstitial Fluid Sampling and a Microfluidic Particle Dam for Visual Quantification of S100A1.
    Wang G; Zhang Y; Kwong HK; Zheng M; Wu J; Cui C; Chan KWY; Xu C; Chen TH
    Adv Sci (Weinh); 2024 Apr; 11(16):e2306188. PubMed ID: 38417122
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Screening out molecular pathways and prognostic biomarkers of ultraviolet-mediated melanoma through computational techniques.
    Hossain A; Ahsan A; Hasan I; Sohel ; Khan A; Somadder PD; Monjur S; Miah S; Kibria KMK; Ahmed K; Rahman H
    Int J Biol Markers; 2024 Jun; 39(2):118-129. PubMed ID: 38410032
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Risk of progression of early-stage mycosis fungoides, 10-year experience.
    Ariza Gómez SA; Dubeibe Abril PA; Niebles Sincelejo OE; Reina HSL
    An Bras Dermatol; 2024; 99(3):407-413. PubMed ID: 38395632
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A rare synchronous presentation of primary malignant melanoma in cervix and vagina.
    Pai UKN; Pillai S; Arunkumar NR
    J Cancer Res Ther; 2023 Oct; 19(7):2108-2110. PubMed ID: 38376333
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Recent treatment and prognosis in 643 patients with extramammary Paget's disease.
    Hatta N; Ogata D; Asai J; Maekawa T; Ito T; Takenouchi T; Kiniwa Y; Miyashita A; Miyagawa T; Muto I; Yamamoto Y; Nagano T; Kiyohara Y; Nakano E; Ohe S; Yamaguchi B; Fukuyama M; Matsuya T; Tsutsumida A; Namikawa K; Yamazaki N
    Exp Dermatol; 2024 Feb; 33(2):e15030. PubMed ID: 38375900
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IB.
    Amaral T; Nanz L; Stadler R; Berking C; Ulmer A; Forschner A; Meiwes A; Wolfsperger F; Meraz-Torres F; Chatziioannou E; Martus P; Flatz L; Garbe C; Leiter U
    Eur J Cancer; 2024 Apr; 201():113912. PubMed ID: 38368742
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lived Experiences and Fear of cancer Recurrence Among Survivors of Localized Cutaneous Melanoma.
    Mahama AN; Haller CN; Labrada J; Idiong CI; Haynes AB; Jacobs EA; Tsevat J; Pignone MP; Adamson AS
    JAMA Dermatol; 2024 May; 160(5):495-501. PubMed ID: 38353983
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.
    Herwig-Carl MC; Sharma A; Tischler V; Pelusi N; Loeffler KU; Holz FG; Zeschnigk M; Landreville S; Auw-Haedrich C; Noberini R; Bonaldi T
    Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):27. PubMed ID: 38349785
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma.
    de Bruyn DP; van Poppelen NM; Brands T; van den Boom SC; Eikenboom E; Wagner A; van Veghel-Plandsoen MM; Geeven G; Beverloo B; van Rij CM; Verdijk RM; Naus NC; Bagger MM; Kiilgaard JF; de Klein A; Brosens E; Kiliç E
    Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):11. PubMed ID: 38319670
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 104.